References
- Pearson GD, Veille JC, Rahimtoola S, Hsia J, Oakley CM, Hosenpud JD, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. J Am Med Assoc. 2000;283:1183–8.
- Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000;140:785–91.
- Hibbard JU, Lindheimer M, Lang R. A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstet Gyneco. 1999;94:311–6.
- Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: Diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58:659–70.
- Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: An omnious diagnosis. Am J Obstet Gynecol. 1997;176: 182–8.
- Chapa JB, Heiberger HB, Weinert L, DeCara J, Lang R, Hibbard JU. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet Gynecol. 2005;105:1303–8.
- Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, et al. Frequency of peripartum cardiomyopathy. Am J Cardiol. 2006;97:1765–8.
- Brar SS, Khan SS, Sandhu GK, Jorgensen MB, Parikh N, Hsu JW, et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am J Cardiol. 2007;100:302–4.
- van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JD, Paulus WJ, et al. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010;121:2169–75.
- Anderson JL, Horne BD. Birthing the genetics of peripartum cardiomyopathy. Circulation 2010;121:2157–9.
- Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010;121:2176–82.
- Ramaraj R, Sorrell VL. Peripartum cardiomyopathy: Causes, diagnosis and treatment. Cleve Clin J Med. 2009;76:289–96.
- Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007;128:589–600.
- Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: A proof of concept pilot study. Circulation 2010;121:1465–73.
- Lang RM, Lampert MB, Poppas A, Hameed A, Elkayam U. Peripartal cardiomyopathy. In: Elkayam U, Gleicher N, editors. Cardiac problems in pregnancy. 3rd edition. New York, NY: Wiley-Liss; 1998. pp. 87–100.
- Groesdonk HV, Dinse-Lambracht A, Doblanzki W, Doblanzki U, Galm C, Muth C-M. Unrecognized peripartum cardiomyopathy, case series and comprehensive review of literature. Appl Cardiopulm Pathophysiol. 2009;13:237–42.
- Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2009;15:645–50.
- Lok SI, Kirkels JH, Klöpping C, Doevendans PAF, de Jonge N. Peripartum cardiomyopathy: The need for a national database. Neth Heart J. 2011;19:126–33.
- Witlin AG, Mabie WC, Sibai BM. Peripartum cardiomyopathy: A longitudinal echocardiographic study. Am J Obstet Gynecol. 1997;177:1129–32.
- Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, et al. Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation 2005;11:2050–5.
- Kawano H, Tsuneto A, Koide Y, Tasaki H, Sueyoshi E, Sakamoto I, et al. Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Intern Med 2008;47: 97–102.
- Webb JA, Thomsen HS, Morcos SK. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234–40.
- Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W, et al. Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2008;10:861–8.
- Murali S, Marie M, Baldisseri M. Peripartum cardiomyopathy. Crit Care Med. 2005;33:340–6.
- Briggs GG, Freeman RK, Yatte SJ. Drugs in pregnancy and lactation. 8th edition Philadelphia, PA: Wolters Kluwer; 2008.
- Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) study group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–43.
- B ltmann BD, Klingel K, N bauer M, Wallwiener D, Kandolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005;193:363–5.
- Amos AM, Jaber W, Russell SD. Improved outcome in peripartum cardiomyopathy with contemporary. Am Heart J. 2006;152: 509–513.
- Sliwa K, Skudicky D, Bergemann A, Candy G, Puren A, Sareli P. Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. J Am CollCardiol. 2000;35:701–5.
- Whitehead SJ, Berg CJ, Chang J. Pregnancy-related mortality due to cardiomyopathy: United States, 1991–1997. Obstet Gynecol. 2003;102:1326–31.
- Hu CL, Li YB, Zou YG, Zhang JM, Chen JB, Liu J, et al. Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007;93:488–90.
- Safirstein JG, Ro AS, Grandhi S, Wang L, Fett JD, Staniloae C. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154:27–31.
- Elkayam U, Tummala PP, Rao K, Akhter MW, Karaalp IS, Wani OR, et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy N Engl J Med. 2001;344:1567–71Erratum: N Engl J Med.2001;345: 552.